This publication is devoted to the description of the drug "Chondrolon", the use of which allows you to successfully treat degenerative pathologies of the joints and spine. This pharmaceutical agent has proven itself in traumatology in the treatment of so-called "sports injuries." Contributing to the normalization of metabolic processes in hyaline cartilage, the drug is effective in rehabilitation therapy.
The active substance of the described medication is chondroitin sulfate (chondroitin sulfate). The medicine is available in capsules, tablets, solutions, as well as in a lyophilisate, intended for self-preparation of a solution for injection.
Pharmacological properties
The medicine "Chondrolone" calls the instructions for use a drug that affects the metabolic processes that occur in hyaline cartilage. The active substance is a high molecular weight mucopolysaccharide capable of slowing down bone resorption and reducing calcium loss. As a result, the mobility of the affected joints improves, and joint pain also decreases. Symptoms of reactive synovitis are eliminated.
Indications for treatment with the drug "Chondrolon" instructions for use call degenerative articular pathology, diseases of the spine:
Positive results usually appear fourteen days after the start of treatment. When ingesting tablets / capsules of the drug "Chondrolon", the instructions for use prescribe drinking them with water in a small amount. For 21 days, adult patients take twice a day 0.75 g per dose. Subsequent treatment continues with 0.5 g of the drug. The most effective is the therapy of the above pathologies with the help of the intramuscular injection of the pharmaceutical agent “Chondrolon”.
Contraindications to the use in the treatment of this drug are, first of all, thrombosis, as well as hypersensitivity to this medication and high bleeding.
Side effects were manifested (in rare cases) in the form of allergic reactions, hemorrhages (hemorrhages) were observed at the injection sites. Such manifestations require termination of treatment using this drug.
With intramuscular administration of the Chondrolon solution, up to thirty injections (25-30) are prescribed during the course of treatment. The lyophilisate is dissolved in 1 ml of water for injection. One injection is performed intramuscularly every other day in a single ampoule - 100 mg. If the treatment is well tolerated by the patient, then the dosage is doubled. After the third injection, two ampoules of the drug (200 mg) are administered IM to the patient.
If necessary, repeated courses of therapy are carried out, but not earlier than after six months after completion of the previous one. During rehabilitation therapy with the described drug, physiotherapy exercises and physiotherapeutic treatment are additionally recommended. Circular showers, herbal tea, diet therapy, therapeutic baths, dosed walking are prescribed.
special instructions
You should stop treatment with the drug in the above cases of side effects. There is currently no confirmed evidence of an overdose of this drug. Also, there are no data on the treatment with the medicine "Chondrolon" of young children and pregnant women.
As for joint therapy with other medicinal substances, the possibility of strengthening fibrinolytics, indirect anticoagulants, antiplatelet agents is not excluded.
Before proceeding with treatment with the “Chondrolon” medicine (the instructions for using this medication remind of this), you should definitely consult a specialist in order to avoid harm to health.